Netilmicin therapy of gentamicin-sensitive and resistant gram-negative infections.
D001424:Bacterial Infections / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D005839:Gentamicins / Q000627:therapeutic use*; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D007759:Labyrinth Diseases / Q000139:chemically induced; D009428:Netilmicin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D010538:Peritonitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013530:Surgical Wound Infection / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy; D014722:Vestibule, Labyrinth / Q000187:drug effects
D005839:Gentamicins; D009428:Netilmicin